PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
8612498-4	1996	Cortisol infusion (230 micrograms/h for 48 h) at 108 +/- 1 day decreased renal Epo gene expression significantly (P < 0.01) to 23% of the control value; dexamethasone treatment of the ewe at midgestation (0.76 mg/h for 48 h) also decreased fetal, but not adult, renal Epo mRNA levels (to 12% of control value; P < 0.01).	Dexamethasone	156-169	erythropoietin	Ovis aries	79-82	
8612498-4	1996	Cortisol infusion (230 micrograms/h for 48 h) at 108 +/- 1 day decreased renal Epo gene expression significantly (P < 0.01) to 23% of the control value; dexamethasone treatment of the ewe at midgestation (0.76 mg/h for 48 h) also decreased fetal, but not adult, renal Epo mRNA levels (to 12% of control value; P < 0.01).	Dexamethasone	156-169	erythropoietin	Ovis aries	271-274	
8025273-2	1994	The effect of dexamethasone infusion in the ewe on Epo gene expression in the 60-day fetus was also investigated.	Dexamethasone	14-27	erythropoietin	Ovis aries	51-54	
8025273-6	1994	Treatment of ewes carrying 60-day fetuses with 0.76 mg/h dexamethasone for 48 hours resulted in a significant decrease in fetal plasma Epo values and Epo mRNA levels in both the liver and kidney.	Dexamethasone	57-70	erythropoietin	Ovis aries	135-138	
8025273-6	1994	Treatment of ewes carrying 60-day fetuses with 0.76 mg/h dexamethasone for 48 hours resulted in a significant decrease in fetal plasma Epo values and Epo mRNA levels in both the liver and kidney.	Dexamethasone	57-70	erythropoietin	Ovis aries	150-153	
8025273-7	1994	In the dexamethasone-treated fetuses, Epo mRNA in the liver was 52% of control values (P < .05), and in the kidney, 33% of control (P < .001).	Dexamethasone	7-20	erythropoietin	Ovis aries	38-41